The search for NKCC1-selective drugs for the treatment of epilepsy: Structure–function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A

布美他尼 协同运输机 化学 药理学 爪蟾 癫痫 乙酰唑胺 利尿剂 运输机 速尿 潘特林 氯化物 生物化学 医学 钠 基因 有机化学
作者
Kasper Lykke,Kathrin Töllner,Peter W. Feit,Thomas Erker,Nanna MacAulay,Wolfgang Löscher
出处
期刊:Epilepsy & Behavior [Elsevier BV]
卷期号:59: 42-49 被引量:48
标识
DOI:10.1016/j.yebeh.2016.03.021
摘要

The Na(+)-K(+)-Cl(-) cotransporter NKCC1 plays a major role in the regulation of intraneuronal Cl(-) concentration. Abnormal functionality of NKCC1 has been implicated in several brain disorders, including epilepsy. Bumetanide is the only available selective NKCC1 inhibitor, but also inhibits NKCC2, which can cause severe adverse effects during treatment of brain disorders. A NKCC1-selective bumetanide derivative would therefore be a desirable option. In the present study, we used the Xenopus oocyte heterologous expression system to compare the effects of bumetanide and several derivatives on the two major human splice variants of NKCCs, hNKCC1A and hNKCC2A. The derivatives were selected from a series of ~5000 3-amino-5-sulfamoylbenzoic acid derivatives, covering a wide range of structural modifications and diuretic potencies. To our knowledge, such structure-function relationships have not been performed before for NKCC1. Half maximal inhibitory concentrations (IC50s) of bumetanide were 0.68 (hNKCC1A) and 4.0μM (hNKCC2A), respectively, indicating that this drug is 6-times more potent to inhibit hNKCC1A than hNKCC2A. Side chain substitutions in the bumetanide molecule variably affected the potency to inhibit hNKCC1A. This allowed defining the minimal structural requirements necessary for ligand interaction. Unexpectedly, only a few of the bumetanide derivatives examined were more potent than bumetanide to inhibit hNKCC1A, and most of them also inhibited hNKCC2A, with a highly significant correlation between IC50s for the two NKCC isoforms. These data indicate that the structural requirements for inhibition of NKCC1 and NKCC2 are similar, which complicates development of bumetanide-related compounds with high selectivity for NKCC1.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
情怀的应助被dianhuaxue采纳,获得10
刚刚
深情安青的应助被俭朴南风采纳,获得10
刚刚
1秒前
lili完成签到 ,获得积分10
1秒前
爆爆发布了新的文献求助10
1秒前
云海完成签到,获得积分10
2秒前
2秒前
Anna完成签到,获得积分10
3秒前
Licy完成签到,获得积分10
3秒前
3秒前
4秒前
干净的天蓉完成签到,获得积分20
4秒前
科研通AI6.4的应助被王萍有采纳,获得10
4秒前
antrun发布了新的文献求助10
4秒前
5秒前
null的应助被日月雨辰采纳,获得10
5秒前
8秒前
9秒前
Lucas的应助被SFF采纳,获得10
9秒前
动人的电灯胆完成签到,获得积分10
10秒前
CipherSage的应助被Paranoieam采纳,获得10
10秒前
烟花的应助被幸运的成仁采纳,获得10
12秒前
霸气刺猬完成签到,获得积分10
12秒前
12秒前
喆减一完成签到,获得积分20
12秒前
likemangren发布了新的文献求助10
13秒前
科研通AI6.3的应助被苍蓝星采纳,获得10
13秒前
14秒前
123完成签到,获得积分10
14秒前
14秒前
14秒前
14秒前
15秒前
科研通AI6.3的应助被牧百川采纳,获得10
15秒前
xjj发布了新的文献求助10
16秒前
17秒前
天梦星玄完成签到,获得积分10
17秒前
刘玉强完成签到,获得积分10
17秒前
李健的应助被明理的依柔采纳,获得10
17秒前
慕青的应助被嗷嗷采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183298
求助须知:如何正确求助?哪些是违规求助? 9572606
关于积分的说明 21826444
捐赠科研通 7780272
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558136
邀请新用户注册赠送积分活动 2480259